127 related articles for article (PubMed ID: 38235681)
1. Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.
Tongruang C; Wananukul S; Chatproedprai S; Narkbunnam N; Nitiyarom R; Sirachainan N; Natesirinilkul R; Chaweephisal P; Sosothikul D
Pediatr Hematol Oncol; 2024 Apr; 41(3):229-239. PubMed ID: 38235681
[TBL] [Abstract][Full Text] [Related]
2. Refractory Kasabach-Merritt phenomenon successfully treated with sirolimus, and a mini-review of the published work.
Wang Z; Li K; Dong K; Xiao X; Zheng S
J Dermatol; 2015 Apr; 42(4):401-4. PubMed ID: 25728547
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus for Vincristine-Resistant Kasabach-Merritt Phenomenon: Report of Eight Patients.
Wang H; Duan Y; Gao Y; Guo X
Pediatr Dermatol; 2017 May; 34(3):261-265. PubMed ID: 28198567
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
[TBL] [Abstract][Full Text] [Related]
5. Cocktail therapy with prednisolone, vincristine and sirolimus for Kasabach‑Merritt phenomenon in 10 infants.
Liu Q; Xiong N; Gong X; Tong H; Tan X; Guo X
Exp Ther Med; 2022 Oct; 24(4):621. PubMed ID: 36160903
[TBL] [Abstract][Full Text] [Related]
6. Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.
Harbers VEM; van der Salm N; Pegge SAH; van der Vleuten CJM; Verhoeven BH; Vrancken SLAG; Schultze Kool LJ; Fuijkschot J; Te Loo DMMWM
Br J Clin Pharmacol; 2022 Jun; 88(6):2769-2781. PubMed ID: 34957601
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of transcatheter arterial chemoembolization combined with sirolimus for treating Kasabach-Merritt phenomenon in infants, a retrospective study.
Yin CG; Qi WW; Wang S; Pan D; Chen XL; Li SY
Ann Med; 2023 Dec; 55(1):2196090. PubMed ID: 37038342
[TBL] [Abstract][Full Text] [Related]
9. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
[TBL] [Abstract][Full Text] [Related]
10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
11. [Refractory kaposiforme hemangioendothelioma in the pediatric population: case report and literature review.].
Gómez-Villegas CP; Pérez-Téllez C; Ochoa-Gaviria J; Builes N
Bol Med Hosp Infant Mex; 2021; 78(4):376-384. PubMed ID: 34351887
[TBL] [Abstract][Full Text] [Related]
12. Successful management of steroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon using sirolimus.
Tan X; Zhang J; Zhou S; Liu Z; Zhang T; Xia J
J Dermatol; 2018 May; 45(5):580-583. PubMed ID: 29356076
[TBL] [Abstract][Full Text] [Related]
13. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
Peng S; Yang K; Xu Z; Chen S; Ji Y
J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate.
Cabrera TB; Speer AL; Greives MR; Goff DA; Menon NM; Reynolds EW
AJP Rep; 2020 Oct; 10(4):e390-e394. PubMed ID: 33214934
[TBL] [Abstract][Full Text] [Related]
15. Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma.
Wang L; Li J; Wu C; Song D; Liu Z; Niu Y; Zhou J; Guo L
Front Pediatr; 2022; 10():949950. PubMed ID: 35990005
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy for pediatric patients with Kasabach-Merritt phenomenon: A single-center retrospective study.
Zhang L; Liu L; Luo H; Xu W; Chen H; Yan M; Wang Y
Medicine (Baltimore); 2022 Aug; 101(34):e30296. PubMed ID: 36042656
[TBL] [Abstract][Full Text] [Related]
17. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options.
Mahajan P; Margolin J; Iacobas I
Clin Med Insights Blood Disord; 2017; 10():1179545X17699849. PubMed ID: 28579853
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
19. Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management.
Ji Y; Yang K; Chen S; Peng S; Lu G; Liu X
Cancer Manag Res; 2018; 10():3325-3331. PubMed ID: 30233248
[TBL] [Abstract][Full Text] [Related]
20. Case report: Blue rubber bleb nevus syndrome with Kasabach-Merritt phenomenon in a neonate.
Pi M; Zhao L; Xu W; Xu M; Ding Y
Front Pediatr; 2023; 11():1131094. PubMed ID: 37152317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
